A woman from Ohio asked for a court's permission to allow a hospital to use Ivermectin in treatment of her husband with COVID-19.
WXIX reports that Gregory Howard, a Butler County judge, ruled in her favor.
Ivermectin, a deworming medication, is not approved to treat COVID-19.
Loading... Click to sign up for marketing emails from Insider and other partners. You also agree to our Terms of Service & Privacy Policy
Multiple outlets reported that an Ohio judge ordered a hospital in the state to administer the deworming drug, ivermectin, on a COVID-19 victim.
Gregory Howard, a Butler County judge, ruled in favor a woman who requested that her husband, West Chester Hospital's COVID-19-equipped ventilator, be treated with an unproven drug.
Jeffrey Smith, 51, was diagnosed with COVID-19 early in July. Julie Smith, his wife, requested an emergency order from the court to use the drug on Jeffrey Smith, 51, on August 20.
Howard ruled on August 23 that Fred Wagshul could give Smith 30mg daily of the drug for three weeks. WXIX reported.
"The countries we have seen have all emptied their hospitals. "This medicine is very effective," Dr. Wagshul stated to the outlet.
Wagshul, a Dayton-based pulmonologist, is also a cofounder of Front Line COVID-19 Critical Care Alliance. This non-profit promotes the use ivermectin in COVID-19.
The Centers for Disease Control and Prevention and Food and Drug Administration warn that this drug has not been proven to be effective in treating COVID-19 and may have dangerous side effects.
The CDC issued a health advisory last Wednesday stating that the FDA-approved drug could be used safely to treat parasitic infections, but may be dangerous in other settings.
The CDC is particularly concerned about the rise in poison control calls due to people using versions of the drug that are meant for horses or cows. The number of poison control calls regarding the drug increased fivefold in the last month, compared with the baseline numbers before the pandemic.
Insider reached out to Wagshul, FLCCC and for more information.